Hormone Replacement Therapy Market Analysis and Forecast to 2032: By Therapy Type (Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy, Progestogen Hormone Replacement Therapy), Route of Administration (Oral, Parenteral, Transdermal), Indication (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Others), and Region
The Hormone Replacement Therapy Market was valued at 19.9 billion in 2022 and it is anticipated to grow up to USD 36.4 billion by 2032, at a CAGR of 6.2% during the forecast period.
hormone replacement therapy (HRT) is a treatment technique for replacing and/or replenishing hormones in the human body, which are at inadequate levels than those required for the normal physiology of the human body. The most prominent application of HRT is in the treatment of symptom alleviation of menopause.
Hormone Replacement Therapy Market Scope and Report Structure
| Report Attribute | Details |
|---|---|
| Market Size in 2021 | $19.9 bn |
| Market Size in 2031 | $36.4 bn |
| Growth Rate (2021-31) | 6.2% |
| Historic Period | 2016-2021 |
| Forecast Period | 2023-2032 |
| Base Year | 2022 |
| Segments Covered | Therapy Type, Route of Administration, Indication, and Region |
| Key Companies | AbbVie (U.S.), Allergan plc (U.S.), Amgen (U.S.), Bayer AG (Germany), Belmar Pharma Solutions (U.S.), Endo International plc (Ireland), Merck KGaA (Germany), Mithra Pharmaceuticals (Belgium), Novo Nordisk A/S (Denmark), and Pfizer Inc. (U.S.). |
| Regional Scope | North America, Europe, Asia Pacific, Central & South America, Middle East & Africa |
| Analysis Coverage | Market Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments |
Market Trends and Drivers
One significant growth driver for the Hormone Replacement Therapy (HRT) market is the increasing awareness and acceptance of hormone replacement therapies for managing symptoms associated with menopause. As more women become educated about the benefits of HRT in alleviating hot flashes, night sweats, vaginal dryness, and other menopausal symptoms, the demand for these therapies is expected to rise. Moreover, with advancements in medical research and technology, the development of innovative and more targeted hormone therapies has become possible, catering to individual patient needs and preferences. This expanding range of treatment options, coupled with a growing aging population worldwide, is anticipated to fuel the growth of the HRT market in the coming years.
Market Restraints and Challenges
One of the key restraints in the Hormone Replacement Therapy (HRT) market is the potential risk associated with long-term use of hormone replacement products. While HRT can provide relief from menopausal symptoms and other hormonal imbalances, studies have suggested an increased risk of certain health conditions, such as cardiovascular diseases and certain types of cancer, with prolonged use of HRT. These safety concerns have led to cautious prescribing practices and decreased patient acceptance, limiting the growth potential of the HRT market. Additionally, the availability of alternative therapies and the preference for non-hormonal treatment options further restraining the market growth.
Hormone Replacement Therapy Market Segmental Overview
The report analyses the global Hormone Replacement Therapy Market based on Therapy Type, Route of Administration, Indication, and Region.
Hormone Replacement Therapy Market by Therapy Type
Based on Therapy Type, it is analyzed across Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy, and Progestogen Hormone Replacement Therapy. The estrogen and progesterone replacement therapy segment emerged as the dominant market leader in the peptide synthesis industry. This significant market share can be attributed to the rising demand for hormone replacement therapies among individuals experiencing hormonal imbalances or undergoing menopause. According to the American Congress of Obstetricians and Gynecologists, around 6,000 women reach menopause daily in the U.S. Estrogen and progesterone replacement therapies are widely used to alleviate symptoms and promote overall well-being, thereby driving the growth of this particular segment in the peptide synthesis market.
Moreover, advancements in peptide synthesis technologies and the availability of innovative delivery systems have further propelled the adoption of estrogen and progesterone replacement therapy. As the aging population continues to expand globally and individuals seek ways to manage hormonal imbalances and associated symptoms, the estrogen and progesterone replacement therapy segment is expected to maintain its strong market position. The peptide synthesis market will continue to witness significant growth, driven by the increasing demand for hormone replacement products and ongoing research to develop novel peptides that offer enhanced efficacy and improved patient outcomes.
Hormone Replacement Therapy Market by Route of Administration
Based on route of administration, it is categorized into parenteral, oral, and transdermal. During the projected period, the parenteral segment is anticipated to experience significant growth. This growth can be attributed to advancements in drug delivery methods, particularly through pen-based drug delivery systems. These systems are expected to enhance patient compliance and simplify administration, thus driving the expansion of this segment. Some popular pen-based products include the Genotropin Mixer Pen, Norditropin FlexPro Pen, and Humatrope HumatroPen.
Additionally, the introduction of a new long-acting growth hormone injection is predicted to further fuel the growth of this segment. For example, in January 2022, Pfizer, Inc. and OPKO Health, Inc. obtained approval from the Ministry of Health, Labour and Welfare in Japan to market NGENLA, a next-generation long-acting growth hormone injection for treating growth hormone disorders. This product offers the advantage of a once-a-week dosage regimen, contributing to its potential impact on segment growth.
Hormone Replacement Therapy Market by Indication
On the basis of Indication, it is segmented into Hypothyroidism, Menopause, Male Hypogonadism, Growth Hormone Deficiency, and Others. In 2022, the hypoparathyroidism segment is anticipated to experience substantial growth in the forecast period, driven by the development of novel treatments and the introduction of new products. For instance, in September 2020, Ascendis Pharma A/S presented its TransCon technologies at the American Society for Bone and Mineral Research (ASBMR) 2020 Annual Meeting. The company also disclosed the top-line results of the phase 2 clinical trial for TransCon PTH at the same event. Currently, the drug is undergoing phase 3 clinical trials. Upon approval and subsequent launch, this product will offer additional options for parathyroid hormone replacement therapy
On the other hand, menopause segment emerged as the dominant force in the market, capturing a share. This can be attributed to the rising number of women experiencing menopause. According to the UN’s 2020 global estimates, there were 958 million women aged 50 and above, and this number is projected to reach 1.65 billion by 2050. As a result, a significant population of women is expected to spend a considerable portion of their lives after menopause in the future. However, the age of menopause can vary due to various factors, including natural factors such as habitat and genetics, which influence the timing of menopause for individuals.
Regional Analysis of Hormone Replacement Therapy Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America is projected to maintain its dominant position in the Hormone Replacement Therapy market throughout the forecast period. This region is expected to experience substantial growth throughout the forecast period. The significant market share can be attributed to several factors, including major product launches, collaborative agreements among manufacturers, and favorable reimbursement policies. An example of such a success is the approval of Sogroya (somapacitan-beco), a hormone replacement therapy product developed by Novo Nordisk A/S, by the U.S. FDA in August 2020. This particular product is administered once weekly via the subcutaneous route and is targeted towards adults diagnosed with growth hormone deficiency. The region’s strong healthcare infrastructure, increasing geriatric population, rising prevalence of hormonal disorders, and extensive research and development activities contribute to its leadership position. Additionally, favorable reimbursement policies, high healthcare expenditure, and robust pharmaceutical industry further propel the growth of the HRT market in North America, attracting both domestic and international players to invest in this lucrative market segment.
Major Players in the Hormone Replacement Therapy Market
Market players are focusing on strategic collaborations to enhance their product offerings. Some prominent participants in the global Hormone Replacement Therapy market include AbbVie (U.S.), Allergan plc (U.S.), Amgen (U.S.), Bayer AG (Germany), Belmar Pharma Solutions (U.S.), Endo International plc (Ireland), Merck KGaA (Germany), Mithra Pharmaceuticals (Belgium), Novo Nordisk A/S (Denmark), and Pfizer Inc. (U.S.). among others.
COVID-19 Impact
The Hormone Replacement Therapy market has witnessed a significant impact due to the emergence of COVID-19, as peptides are increasingly being developed and repurposed in the search for therapeutics to treat the virus. According to an update from ClinicalTrials.gov in August 2022, over 100 peptide drugs are currently under development for treating COVID-19, including 15 synthetic peptides specifically targeting acute respiratory distress syndrome (ARDS) and other respiratory illnesses caused by SARS-CoV-2 infection. A 2022 article titled “Peptide-Based Vaccines and Therapeutics for COVID-19” highlighted the usefulness of peptides in addressing the urgent need for alternative COVID-19 therapies. Peptides offer advantages such as target selectivity, improved interactions, and reduced toxicity. Furthermore, minor structural modifications can enhance their metabolism, allowing for prolonged and long-acting effects. Consequently, the Hormone Replacement Therapy market has experienced a significant impact due to the influence of COVID-19.
Recent Developments
- In February 2023, Korea’s Ministry of Food and Drug Safety approved Pfizer’s NGENLA for the treatment of growth hormone deficiency.
- In June 2022, Halozyme Therapeutics, Inc. announced the commercial launch of TLANDO (testosterone undecanoate), an oral treatment indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
- In February 2022, Pfizer Inc. and OPKO Health, Inc. announced that the European Commission has granted marketing authorization for the next-generation long-acting recombinant human growth hormone NGENLA, a once-weekly injection to treat children and adolescents from 3 years of age with growth disturbance due to insufficient secretion of growth hormone.
- In January 2022, Pfizer, Inc. and OPKO Health, Inc. received approval from the Ministry of Health, Labour and Welfare, Japan, for the commercialization of NGENLA to treat growth hormone disorder. This product is the next-generation long-acting growth hormone injection, with a treatment frequency of a once-a-week dosage.
- In November 2021, I-MAB Biopharma Co., Ltd. entered into a collaboration with Jumpcan Pharmaceutical Group for the development & commercialization of eftansomatropin alfa (TJ101) in China. TJ101 is a long-acting recombinant human growth hormone, which is currently under phase 3 clinical trial for the treatment of pediatric growth hormone deficiency. This collaboration is expected to strengthen its position in the hormone replacement therapy market.
- In September 2020, Ascendis Pharma A/S showcased the TransCon technologies at the American Society for Bone and Mineral Research (ASBMR) 2020 Annual Meeting. It also published the top-line results of the phase 2 clinical trial for TransCon PTH at the annual meeting. The drug is currently in phase 3 clinical trials. The approval and subsequent launch of this product will provide more options available for parathyroid hormone replacemen
- In August 2020, U.S. FDA approved Sogroya (somapacitan-beco) a HGH replacement therapy product developed by Novo Nordisk A/S. This product is administered once a weekly through subcutaneous route in adults diagnosed with growth hormone deficiency.
Hormone Replacement Therapy Market Report Coverage
- The report offers a comprehensive quantitative as well as qualitative analysis of the current Hormone Replacement Therapy Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
- The report also covers qualitative as well as quantitative analysis of the Hormone Replacement Therapy market in terms of revenue ($Billion).
- Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Hormone Replacement Therapy Market industry.
- A thorough analysis of market trends and restraints is provided
- By region as well as country market analysis is also presented in this report
- Analytical depiction of the Hormone Replacement Therapy Market along with the current trends and future estimations to depict imminent investment pockets. The overall Hormone Replacement Therapy Market Industry opportunity is examined by understanding profitable trends to gain a stronger foothold
- Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Hormone Replacement Therapy Market are also analyzed.
Frequently Asked Questions
Q1. How big is the Hormone Replacement Therapy market?
Ans. The Hormone Replacement Therapy Market was valued at 19.9 billion in 2022 and it is anticipated to grow up to USD 36.4 billion by 2032, at a CAGR of 6.2% during the forecast period.
Q2. What is the Hormone Replacement Therapy Market growth rate?
Ans. The growth rate of the Hormone Replacement Therapy Market is 6.2%
Q3. Which region holds a major market share for the market?
Ans. North America holds a major market share of the Hormone Replacement Therapy Market in 202.
Q4. Which segment accounted for the largest Hormone Replacement Therapy Market share?
Ans. By indication, the Growth Hormone Deficiency segment accounted for the largest Hormone Replacement Therapy Market share.
Q5. Who are the key players in the Hormone Replacement Therapy market?
Ans. The Hormone Replacement Therapy Market report includes players such as AbbVie (U.S.), Allergan plc (U.S.), Amgen (U.S.), Bayer AG (Germany), Belmar Pharma Solutions (U.S.), Endo International plc (Ireland), Merck KGaA (Germany), Mithra Pharmaceuticals (Belgium), Novo Nordisk A/S (Denmark), and Pfizer Inc. (U.S.). among others.
Q6. What are the factors driving the Hormone Replacement Therapy Market growth?
Ans. The major factors driving the growth of the market are the rising incidence of target diseases and the availability of long-acting hGH products.
Q7. What are the key growth strategies of Hormone Replacement Therapy Market players?
Ans. The key growth strategies of Hormone Replacement Therapy Market players are product launch and product approval.
Q8. Which region will provide more business opportunities for the Hormone Replacement Therapy Market during the forecast period?
Ans. The Asia-Pacific region will provide more business opportunities for the Hormone Replacement Therapy Market during the forecast period.
Table of Contents
Chapter 1. Hormone Replacement Therapy Market Overview
1.1. Objectives of the Study
1.2. Market Definition and Scope of the Report
1.3. Report Limitations
1.4. Years & Currency Considered in the Study
1.5. Research Methodologies
1.5.1. Secondary Research
1.5.1.1. Data Collection
1.5.1.2. List of Secondary Sources
1.5.1.3. Key Data from Secondary Sources
1.5.2. Primary Research
1.5.2.1. List of Primary Research Sources
1.5.3. Market Route of Administration Estimation: Top-Down Approach
1.5.4. Market Route of Administration Estimation: Bottom-Up Approach
1.5.5. Data Triangulation and Validation
Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market
2.3. Analyst’s Review
Chapter 3. Premium Insights on the Market
3.1. Market Attractiveness Analysis, by Region
3.2. Market Attractiveness Analysis, by Therapy Type
3.3. Market Attractiveness Analysis, by Route of Administration
3.4. Market Attractiveness Analysis, by Indication
Chapter 4. Hormone Replacement Therapy Market Outlook
4.1. Hormone Replacement Therapy Market Segmentation
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.1.3. Driver 3
4.2.2. Market Restraints
4.2.2.1. Restraint 1
4.2.2.2. Restraint 2
4.2.3. Market Opportunities
4.2.3.1. Opportunity 1
4.2.3.2. Opportunity 2
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Buyers
4.3.4. Bargaining Power of Supplier
4.3.5. Competitive Rivalry
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.6. Impact of COVID-19 on the Hormone Replacement Therapy Market
4.7. Impact of the Russia and Ukraine War on the Hormone Replacement Therapy Market
4.8. Parent Market Analysis
4.9. Hormone Replacement Therapy Ecosystem Analysis
4.10. Case Study Analysis
4.11. Pricing Analysis
4.12. Regulatory Landscape
4.13. Patent Analysis
4.14. Technology Trend Analysis
Chapter 5. Hormone Replacement Therapy Market, by Therapy Type
5.1. Market Overview
5.2. Estrogen Hormone Replacement Therapy
5.2.1. Key Market Trends & Opportunity Analysis
5.2.2. Market Size and Forecast, by Region
5.3. Human Growth Hormone Replacement Therapy
5.3.1. Key Market Trends & Opportunity Analysis
5.3.2. Market Size and Forecast, by Region
5.4. Thyroid Hormone Replacement Therapy
5.4.1. Key Market Trends & Opportunity Analysis
5.4.2. Market Size and Forecast, by Region
5.5. Testosterone Hormone Replacement Therapy
5.5.1. Key Market Trends & Opportunity Analysis
5.5.2. Market Size and Forecast, by Region
5.6. Progestogen Hormone Replacement Therapy
5.6.1. Key Market Trends & Opportunity Analysis
5.6.2. Market Size and Forecast, by Region
Chapter 6. Hormone Replacement Therapy Market, by Route of Administration
6.1. Market Overview
6.2. Oral
6.2.1. Key Market Trends & Opportunity Analysis
6.2.2. Market Size and Forecast, by Region
6.3. Parenteral
6.3.1. Key Market Trends & Opportunity Analysis
6.3.2. Market Size and Forecast, by Region
6.4. Transdermal
6.4.1. Key Market Trends & Opportunity Analysis
6.4.2. Market Size and Forecast, by Region
Chapter 7. Hormone Replacement Therapy Market, by Indication
7.1. Market Overview
7.2. Menopause
7.2.1. Key Market Trends & Opportunity Analysis
7.2.2. Market Size and Forecast, by Region
7.3. Hypothyroidism
7.3.1. Key Market Trends & Opportunity Analysis
7.3.2. Market Size and Forecast, by Region
7.4. Male Hypogonadism
7.4.1. Key Market Trends & Opportunity Analysis
7.4.2. Market Size and Forecast, by Region
7.5. Growth Hormone Deficiency
7.5.1. Key Market Trends & Opportunity Analysis
7.5.2. Market Size and Forecast, by Region
7.6. Others
7.6.1. Key Market Trends & Opportunity Analysis
7.6.2. Market Size and Forecast, by Region
Chapter 8. Hormone Replacement Therapy Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.2.3. North America Hormone Replacement Therapy Market Size and Forecast, by Indication
8.2.4. North America Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.2.5. The U.S.
8.2.5.1. The U.S. Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.2.5.2. The U.S. Hormone Replacement Therapy Market Size and Forecast, by Indication
8.2.5.3. The U.S. Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.2.6. Canada
8.2.6.1. Canada Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.2.6.2. Canada Hormone Replacement Therapy Market Size and Forecast, by Indication
8.2.6.3. Canada Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.2.7. Mexico
8.2.7.1. Mexico Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.2.7.2. Mexico Hormone Replacement Therapy Market Size and Forecast, by Indication
8.2.7.3. Mexico Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.3.3. Europe Hormone Replacement Therapy Market Size and Forecast, by Indication
8.3.4. Europe Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.3.5. Europe Hormone Replacement Therapy Market Size and Forecast, by Country
8.3.6. The UK
8.3.6.1. The UK Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.3.6.2. The UK Hormone Replacement Therapy Market Size and Forecast, by Indication
8.3.6.3. The UK Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.3.7. Germany
8.3.7.1. Germany Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.3.7.2. Germany Hormone Replacement Therapy Market Size and Forecast, by Indication
8.3.7.3. Germany Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.3.8. France
8.3.8.1. France Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.3.8.2. France Hormone Replacement Therapy Market Size and Forecast, by Indication
8.3.8.3. France Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.3.9. Spain
8.3.9.1. Spain Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.3.9.2. Spain Hormone Replacement Therapy Market Size and Forecast, by Indication
8.3.9.3. Spain Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.3.10. Italy
8.3.10.1. Italy Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.3.10.2. Italy Hormone Replacement Therapy Market Size and Forecast, by Indication
8.3.10.3. Italy Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.3.11. Netherlands
8.3.11.1. Netherlands Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.3.11.2. Netherlands Hormone Replacement Therapy Market Size and Forecast, by Indication
8.3.11.3. Netherlands Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.3.12. Sweden
8.3.12.1. Sweden Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.3.12.2. Sweden Hormone Replacement Therapy Market Size and Forecast, by Indication
8.3.12.3. Sweden Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.3.13. Switzerland
8.3.13.1. Switzerland Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.3.13.2. Switzerland Hormone Replacement Therapy Market Size and Forecast, by Indication
8.3.13.3. Switzerland Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.3.14. Denmark
8.3.14.1. Denmark Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.3.14.2. Denmark Hormone Replacement Therapy Market Size and Forecast, by Indication
8.3.14.3. Denmark Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.3.15. Finland
8.3.15.1. Finland Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.3.15.2. Finland Hormone Replacement Therapy Market Size and Forecast, by Indication
8.3.15.3. Finland Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.3.16. Russia
8.3.16.1. Russia Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.3.16.2. Russia Hormone Replacement Therapy Market Size and Forecast, by Indication
8.3.16.3. Russia Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.3.17. Rest of Europe
8.3.17.1. Rest of Europe Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.3.17.2. Rest of Europe Hormone Replacement Therapy Market Size and Forecast, by Indication
8.3.17.3. Rest of Europe Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.4.3. Asia-Pacific Hormone Replacement Therapy Market Size and Forecast, by Indication
8.4.4. Asia-Pacific Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.4.5. Asia-Pacific Hormone Replacement Therapy Market Size and Forecast, by Country
8.4.6. China
8.4.6.1. China Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.4.6.2. China Hormone Replacement Therapy Market Size and Forecast, by Indication
8.4.6.3. China Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.4.7. India
8.4.7.1. India Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.4.7.2. India Hormone Replacement Therapy Market Size and Forecast, by Indication
8.4.7.3. India Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.4.8. Japan
8.4.8.1. Japan Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.4.8.2. Japan Hormone Replacement Therapy Market Size and Forecast, by Indication
8.4.8.3. Japan Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.4.9. South Korea
8.4.9.1. South Korea Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.4.9.2. South Korea Hormone Replacement Therapy Market Size and Forecast, by Indication
8.4.9.3. South Korea Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.4.10. Australia
8.4.10.1. Australia Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.4.10.2. Australia Hormone Replacement Therapy Market Size and Forecast, by Indication
8.4.10.3. Australia Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.4.11. Singapore
8.4.11.1. Singapore Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.4.11.2. Singapore Hormone Replacement Therapy Market Size and Forecast, by Indication
8.4.11.3. Singapore Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.4.12. Indonesia
8.4.12.1. Indonesia Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.4.12.2. Indonesia Hormone Replacement Therapy Market Size and Forecast, by Indication
8.4.12.3. Indonesia Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.4.13. Taiwan
8.4.13.1. Taiwan Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.4.13.2. Taiwan Hormone Replacement Therapy Market Size and Forecast, by Indication
8.4.13.3. Taiwan Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.4.14. Malaysia
8.4.14.1. Malaysia Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.4.14.2. Malaysia Hormone Replacement Therapy Market Size and Forecast, by Indication
8.4.14.3. Malaysia Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.4.15. Rest of Asia-Pacific
8.4.15.1. Rest of Asia-Pacific Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.4.15.2. Rest of Asia-Pacific Hormone Replacement Therapy Market Size and Forecast, by Indication
8.4.15.3. Rest of Asia-Pacific Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.5. Rest of the World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest of the World Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.5.3. Rest of the World Hormone Replacement Therapy Market Size and Forecast, by Indication
8.5.4. Rest of the World Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.5.5. Rest of the World Hormone Replacement Therapy Market Size and Forecast, by Country
8.5.6. Latin America
8.5.6.1. Latin America Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.5.6.2. Latin America Hormone Replacement Therapy Market Size and Forecast, by Indication
8.5.6.3. Latin America Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.5.7. Middle East
8.5.7.1. Middle East Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.5.7.2. Middle East Hormone Replacement Therapy Market Size and Forecast, by Indication
8.5.7.3. Middle East Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
8.5.8. Africa
8.5.8.1. Africa Hormone Replacement Therapy Market Size and Forecast, by Therapy Type
8.5.8.2. Africa Hormone Replacement Therapy Market Size and Forecast, by Indication
8.5.8.3. Africa Hormone Replacement Therapy Market Size and Forecast, by Route of Administration
Chapter 9. Competitive Landscape
9.1. Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Competitive Leadership Mapping
9.3.1. Star Players
9.3.2. Innovators
9.3.3. Emerging Players
9.4. Vendor Benchmarking
9.5. Developmental Strategy Benchmarking
9.5.1. New Product Developments
9.5.2. Product Launches
9.5.3. Business Expansions
9.5.4. Partnerships, Joint Ventures, and Collaborations
9.5.5. Mergers and Acquisitions
Chapter 10. Company Profiles
10.1. Belmar Pharma Solutions (U.S.)
10.1.1. Company Overview
10.1.2. Company Snapshot
10.1.3. Business Segments
10.1.4. Business Performance
10.1.5. Product offerings
10.1.6. Key Developmental Strategies
10.1.7. SWOT Analysis
10.2. Allergan plc (U.S.)
10.2.1. Company Overview
10.2.2. Company Snapshot
10.2.3. Business Segments
10.2.4. Business Performance
10.2.5. Product offerings
10.2.6. Key Developmental Strategies
10.2.7. SWOT Analysis
10.3. Amgen (U.S.)
10.3.1. Company Overview
10.3.2. Company Snapshot
10.3.3. Business Segments
10.3.4. Business Performance
10.3.5. Product offerings
10.3.6. Key Developmental Strategies
10.3.7. SWOT Analysis
10.4. Bayer AG (Germany)
10.4.1. Company Overview
10.4.2. Company Snapshot
10.4.3. Business Segments
10.4.4. Business Performance
10.4.5. Product offerings
10.4.6. Key Developmental Strategies
10.4.7. SWOT Analysis
10.5. AbbVie’s (U.S.)
10.5.1. Company Overview
10.5.2. Company Snapshot
10.5.3. Business Segments
10.5.4. Business Performance
10.5.5. Product offerings
10.5.6. Key Developmental Strategies
10.5.7. SWOT Analysis
10.6. Endo International plc (Ireland)
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product offerings
10.6.4. Key Developmental Strategies
10.6.5. SWOT Analysis
10.7. Merck KGaA (Germany)
10.7.1. Company Overview
10.7.2. Company Snapshot
10.7.3. Business Segments
10.7.4. Business Performance
10.7.5. Product offerings
10.7.6. Key Developmental Strategies
10.7.7. SWOT Analysis
10.8. Mithra Pharmaceuticals (Belgium)
10.8.1. Company Overview
10.8.2. Company Snapshot
10.8.3. Business Segments
10.8.4. Business Performance
10.8.5. Product offerings
10.8.6. Key Developmental Strategies
10.8.7. SWOT Analysis
10.9. Novo Nordisk A/S (Denmark)
10.9.1. Company Overview
10.9.2. Company Snapshot
10.9.3. Business Segments
10.9.4. Business Performance
10.9.5. Product offerings
10.9.6. Key Developmental Strategies
10.9.7. SWOT Analysis
10.10. Pfizer Inc. (U.S.)
10.10.1. Company Overview
10.10.2. Company Snapshot
10.10.3. Business Segments
10.10.4. Business Performance
10.10.5. Product offerings
10.10.6. Key Developmental Strategies
10.10.7. SWOT Analysis
*The list of companies is subject to change during the final compilation of the report
List of Tables
TABLE 1. Hormone Replacement Therapy Market Size by Therapy Type (USD Billion)
TABLE 2. Hormone Replacement Therapy Market Size by Route of Administration (USD Billion)
TABLE 3. Hormone Replacement Therapy Market Size by Indication (USD Billion)
TABLE 4. Hormone Replacement Therapy Market Size by Region (USD Billion)
TABLE 5. Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 6. Hormone Replacement Therapy Market Size and Forecast for Estrogen Hormone Replacement Therapy, by Region (USD Billion)
TABLE 7. Hormone Replacement Therapy Market Size and Forecast for Human Growth Hormone Replacement Therapy, by Region (USD Billion)
TABLE 8. Hormone Replacement Therapy Market Size and Forecast for Thyroid Hormone Replacement Therapy, by Region (USD Billion)
TABLE 9. Hormone Replacement Therapy Market Size and Forecast for Testosterone Hormone Replacement Therapy, by Region (USD Billion)
TABLE 10. Hormone Replacement Therapy Market Size and Forecast for Progestogen Hormone Replacement Therapy, by Region (USD Billion)
TABLE 11. Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 12. Hormone Replacement Therapy Market Size and Forecast for Oral, by Region (USD Billion)
TABLE 13. Hormone Replacement Therapy Market Size and Forecast for Parenteral, by Region (USD Billion)
TABLE 14. Hormone Replacement Therapy Market Size and Forecast for Transdermal, by Region (USD Billion)
TABLE 15. Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 16. Hormone Replacement Therapy Market Size and Forecast for Menopause, by Region (USD Billion)
TABLE 17. Hormone Replacement Therapy Market Size and Forecast for Hypothyroidism, by Region (USD Billion)
TABLE 18. Hormone Replacement Therapy Market Size and Forecast for Male Hypogonadism, by Region (USD Billion)
TABLE 19. Hormone Replacement Therapy Market Size and Forecast for Growth Hormone Deficiency, by Region (USD Billion)
TABLE 20. Hormone Replacement Therapy Market Size and Forecast for Others, by Region (USD Billion)
TABLE 21. North America Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 22. North America Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 23. North America Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 24. North America Hormone Replacement Therapy Market Size and Forecast, by Country (USD Billion)
TABLE 25. The U.S. Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 26. The U.S. Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 27. The U.S. Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 28. Canada Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 29. Canada Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 30. Canada Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 31. Mexico Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 32. Mexico Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 33. Mexico Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 34. Europe Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 35. Europe Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 36. Europe Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 37. Europe Hormone Replacement Therapy Market Size and Forecast, by Country (USD Billion)
TABLE 38. Germany Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 39. Germany Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 40. Germany Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 41. France Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 42. France Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 43. France Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 44. The UK Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 45. The UK Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 46. The UK Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 47. Spain Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 48. Spain Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 49. Spain Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 50. Italy Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 51. Italy Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 52. Italy Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 53. Netherlands Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 54. Netherlands Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 55. Netherlands Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 56. Sweden Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 57. Sweden Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 58. Sweden Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 59. Switzerland Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 60. Switzerland Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 61. Switzerland Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 62. Denmark Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 63. Denmark Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 64. Denmark Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 65. Russia Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 66. Russia Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 67. Russia Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 68. Rest of Europe Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 69. Rest of Europe Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 70. Rest of Europe Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 71. Asia-Pacific Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 72. Asia-Pacific Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 73. Asia-Pacific Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 74. Asia-Pacific Hormone Replacement Therapy Market Size and Forecast, by Country (USD Billion)
TABLE 75. China Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 76. China Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 77. China Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 78. Japan Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 79. Japan Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 80. Japan Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 81. India Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 82. India Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 83. India Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 84. South Korea Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 85. South Korea Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 86. South Korea Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 87. Australia Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 88. Australia Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 89. Australia Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 90. Netherlands Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 91. Netherlands Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 92. Netherlands Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 93. Singapore Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 94. Singapore Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 95. Singapore Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 96. Indonesia Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 97. Indonesia Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 98. Indonesia Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 99. Taiwan Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 100. Taiwan Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 101. Taiwan Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 102. Malaysia Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 103. Malaysia Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 104. Malaysia Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 105. Rest of Asia-Pacific Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 106. Rest of Asia-Pacific Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 107. Rest of Asia-Pacific Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 108. Rest of the World Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 109. Rest of the World Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 110. Rest of the World Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 111. Rest of the World Hormone Replacement Therapy Market Size and Forecast, by Country (USD Billion)
TABLE 112. Latin America Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 113. Latin America Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 114. Latin America Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 115. Middle East Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 116. Middle East Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 117. Middle East Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 118. Africa Hormone Replacement Therapy Market Size and Forecast, by Therapy Type (USD Billion)
TABLE 119. Africa Hormone Replacement Therapy Market Size and Forecast, by Route of Administration (USD Billion)
TABLE 120. Africa Hormone Replacement Therapy Market Size and Forecast, by Indication (USD Billion)
TABLE 121. Vendor Benchmarking
TABLE 122. Strategy Benchmarking
TABLE 123. Belmar Pharma Solutions (U.S.): Company Snapshot
TABLE 124. Belmar Pharma Solutions (U.S.): Business Segments
TABLE 125. Belmar Pharma Solutions (U.S.): Product offerings
TABLE 126. Belmar Pharma Solutions (U.S.): Key Developmental Strategies
TABLE 127. Allergan plc (U.S.): Company Snapshot
TABLE 128. Allergan plc (U.S.): Business Segments
TABLE 129. Allergan plc (U.S.): Product offerings
TABLE 130. Allergan plc (U.S.): Key Developmental Strategies
TABLE 131. Amgen (U.S.): Company Snapshot
TABLE 132. Amgen (U.S.): Business Segments
TABLE 133. Amgen (U.S.): Product offerings
TABLE 134. Amgen (U.S.): Key Developmental Strategies
TABLE 135. Bayer AG (Germany): Company Snapshot
TABLE 136. Bayer AG (Germany): Business Segments
TABLE 137. Bayer AG (Germany): Product offerings
TABLE 138. Bayer AG (Germany): Key Developmental Strategies
TABLE 139. AbbVie’s (U.S.): Company Snapshot
TABLE 140. AbbVie’s (U.S.): Business Segments
TABLE 141. AbbVie’s (U.S.): Product offerings
TABLE 142. AbbVie’s (U.S.): Key Developmental Strategies
TABLE 143. Endo International plc (Ireland): Company Snapshot
TABLE 144. Endo International plc (Ireland): Business Segments
TABLE 145. Endo International plc (Ireland): Product offerings
TABLE 146. Endo International plc (Ireland): Key Developmental Strategies
TABLE 147. Merck KGaA (Germany): Company Snapshot
TABLE 148. Merck KGaA (Germany): Business Segments
TABLE 149. Merck KGaA (Germany): Product offerings
TABLE 150. Merck KGaA (Germany): Key Developmental Strategies
TABLE 151. Mithra Pharmaceuticals (Belgium): Company Snapshot
TABLE 152. Mithra Pharmaceuticals (Belgium): Business Segments
TABLE 153. Mithra Pharmaceuticals (Belgium): Product offerings
TABLE 154. Mithra Pharmaceuticals (Belgium): Key Developmental Strategies
TABLE 155. Novo Nordisk A/S (Denmark): Company Snapshot
TABLE 156. Novo Nordisk A/S (Denmark): Business Segments
TABLE 157. Novo Nordisk A/S (Denmark): Product offerings
TABLE 158. Novo Nordisk A/S (Denmark): Key Developmental Strategies
TABLE 159. Pfizer Inc. (U.S.): Company Snapshot
TABLE 160. Pfizer Inc. (U.S.): Business Segments
TABLE 161. Pfizer Inc. (U.S.): Product offerings
TABLE 162. Pfizer Inc. (U.S.): Key Developmental Strategies
List of Figures
FIGURE 1. Market Definition and Scope of the Report
FIGURE 2. Research Methodology – Research Design
FIGURE 3. Research Methodology – Demand Side & Supply Side
FIGURE 4. Research Methodology – Data Collection
FIGURE 5. Contribution of Primary Research Vs Secondary Research (%)
FIGURE 6. Research Methodology – List of Secondary Sources
FIGURE 7. Research Methodology – Key Data from Secondary Sources
FIGURE 8. Research Methodology – List of Primary Research Sources
FIGURE 9. Research Methodology – Market Estimation Techniques
FIGURE 10. Research Methodology – Market Route of Administration Estimation: Top-down Approach
FIGURE 11. Research Methodology – Market Route of Administration Estimation: Bottom-up Approach
FIGURE 12. Market Attractiveness Analysis, by Therapy Type
FIGURE 13. Market Attractiveness Analysis, by Route of Administration
FIGURE 14. Market Attractiveness Analysis, by Indication
FIGURE 15. Market Attractiveness Analysis, by Region
FIGURE 16. Market Segmentation
FIGURE 17. Market Dynamics
FIGURE 18. Porter’s Five Forces Analysis
FIGURE 19. Pestle Analysis
FIGURE 20. Value Chain Analysis
FIGURE 21. Impact of Covid-19 Pandemic on Hormone Replacement Therapy Market
FIGURE 22. Hormone Replacement Therapy Market Share, by Region (%)
FIGURE 23. North America Hormone Replacement Therapy Market Share, by Therapy Type (%)
FIGURE 24. North America Hormone Replacement Therapy Market Share, by Route of Administration (%)
FIGURE 25. North America Hormone Replacement Therapy Market Share, by Indication (%)
FIGURE 26. North America Hormone Replacement Therapy Market Share, by Country (%)
FIGURE 27. Europe Hormone Replacement Therapy Market Share, by Therapy Type (%)
FIGURE 28. Europe Hormone Replacement Therapy Market Share, by Route of Administration (%)
FIGURE 29. Europe Hormone Replacement Therapy Market Share, by Indication (%)
FIGURE 30. Europe Hormone Replacement Therapy Market Share, by XX (%)
FIGURE 31. Europe Hormone Replacement Therapy Market Share, by Country (%)
FIGURE 32. Asia-Pacific Hormone Replacement Therapy Market Share, by Therapy Type (%)
FIGURE 33. Asia-Pacific Hormone Replacement Therapy Market Share, by Route of Administration (%)
FIGURE 34. Asia-Pacific Hormone Replacement Therapy Market Share, by Indication (%)
FIGURE 35. Asia-Pacific Hormone Replacement Therapy Market Share, by Country (%)
FIGURE 36. Rest of the World Hormone Replacement Therapy Market Share, by Therapy Type (%)
FIGURE 37. Rest of the World Hormone Replacement Therapy Market Share, by Route of Administration (%)
FIGURE 38. Rest of the World Hormone Replacement Therapy Market Share, by Indication (%)
FIGURE 39. Rest of the World Hormone Replacement Therapy Market Share, by Country (%)
FIGURE 40. Players Covered: Ranking by Hormone Replacement Therapy Market Revenue
FIGURE 41. Market Share Analysis, by Top Players (%)
FIGURE 42. Competitive Leadership Mapping
FIGURE 43. Belmar Pharma Solutions (U.S.): Net Sales, 2020-2022 (USD Billion)
FIGURE 44. Belmar Pharma Solutions (U.S.): R&D Expenditure, 2020-2022 (USD Billion)
FIGURE 45. Belmar Pharma Solutions (U.S.): Segmental Shares, 2022 (%)
FIGURE 46. Belmar Pharma Solutions (U.S.): Regional Shares, 2022 (%)
FIGURE 47. Belmar Pharma Solutions (U.S.): SWOT Analysis
FIGURE 48. Allergan plc (U.S.): Net Sales, 2020-2022 (USD Billion)
FIGURE 49. Allergan plc (U.S.): R&D Expenditure, 2020-2022 (USD Billion)
FIGURE 50. Allergan plc (U.S.): Segmental Shares, 2022 (%)
FIGURE 51. Allergan plc (U.S.): Regional Shares, 2022 (%)
FIGURE 52. Allergan plc (U.S.): SWOT Analysis
FIGURE 53. Amgen (U.S.): Net Sales, 2020-2022 (USD Billion)
FIGURE 54. Amgen (U.S.): R&D Expenditure, 2020-2022 (USD Billion)
FIGURE 55. Amgen (U.S.): Segmental Shares, 2022 (%)
FIGURE 56. Amgen (U.S.): Regional Shares, 2022 (%)
FIGURE 57. Amgen (U.S.): SWOT Analysis
FIGURE 58. Bayer AG (Germany): Net Sales, 2020-2022 (USD Billion)
FIGURE 59. Bayer AG (Germany): R&D Expenditure, 2020-2022 (USD Billion)
FIGURE 60. Bayer AG (Germany): Segmental Shares, 2022 (%)
FIGURE 61. Bayer AG (Germany): Regional Shares, 2022 (%)
FIGURE 62. Bayer AG (Germany): SWOT Analysis
FIGURE 63. AbbVie’s (U.S.): Net Sales, 2020-2022 (USD Billion)
FIGURE 64. AbbVie’s (U.S.): R&D Expenditure, 2020-2022 (USD Billion)
FIGURE 65. AbbVie’s (U.S.): Segmental Shares, 2022 (%)
FIGURE 66. AbbVie’s (U.S.): Regional Shares, 2022 (%)
FIGURE 67. AbbVie’s (U.S.): SWOT Analysis
FIGURE 68. Endo International plc (Ireland): Net Sales, 2020-2022 (USD Billion)
FIGURE 69. Endo International plc (Ireland): R&D Expenditure, 2020-2022 (USD Billion)
FIGURE 70. Endo International plc (Ireland): Segmental Shares, 2022 (%)
FIGURE 71. Endo International plc (Ireland): Regional Shares, 2022 (%)
FIGURE 72. Endo International plc (Ireland): SWOT Analysis
FIGURE 73. Merck KGaA (Germany): Net Sales, 2020-2022 (USD Billion)
FIGURE 74. Merck KGaA (Germany): R&D Expenditure, 2020-2022 (USD Billion)
FIGURE 75. Merck KGaA (Germany): Segmental Shares, 2022 (%)
FIGURE 76. Merck KGaA (Germany): Regional Shares, 2022 (%)
FIGURE 77. Merck KGaA (Germany): SWOT Analysis
FIGURE 78. Mithra Pharmaceuticals (Belgium): Net Sales, 2020-2022 (USD Billion)
FIGURE 79. Mithra Pharmaceuticals (Belgium): R&D Expenditure, 2020-2022 (USD Billion)
FIGURE 80. Mithra Pharmaceuticals (Belgium): Segmental Shares, 2022 (%)
FIGURE 81. Mithra Pharmaceuticals (Belgium): Regional Shares, 2022 (%)
FIGURE 82. Mithra Pharmaceuticals (Belgium): SWOT Analysis
FIGURE 83. Novo Nordisk A/S (Denmark): Net Sales, 2020-2022 (USD Billion)
FIGURE 84. Novo Nordisk A/S (Denmark): R&D Expenditure, 2020-2022 (USD Billion)
FIGURE 85. Novo Nordisk A/S (Denmark): Segmental Shares, 2022 (%)
FIGURE 86. Novo Nordisk A/S (Denmark): Regional Shares, 2022 (%)
FIGURE 87. Novo Nordisk A/S (Denmark): SWOT Analysis
FIGURE 88. Pfizer Inc. (U.S.): Net Sales, 2020-2022 (USD Billion)
FIGURE 89. Pfizer Inc. (U.S.): R&D Expenditure, 2020-2022 (USD Billion)
FIGURE 90. Pfizer Inc. (U.S.): Segmental Shares, 2022 (%)
FIGURE 91. Pfizer Inc. (U.S.): Regional Shares, 2022 (%)
FIGURE 92. Pfizer Inc. (U.S.): SWOT Analysis
Key Players
- AbbVie (U.S.)
- Allergan plc (U.S.)
- Amgen (U.S.)
- Bayer AG (Germany)
- Belmar Pharma Solutions (U.S.)
- Endo International plc (Ireland)
- Merck KGaA (Germany)
- Mithra Pharmaceuticals (Belgium)
- Novo Nordisk A/S (Denmark)
- Pfizer Inc. (U.S.)
Market Segments
By Therapy Type
- Estrogen Hormone Replacement Therapy
- Human Growth Hormone Replacement Therapy
- Thyroid Hormone Replacement Therapy
- Testosterone Hormone Replacement Therapy
- Progestogen Hormone Replacement Therapy
By Route of Administration
- Oral
- Parenteral
- Transdermal
By Indication
- Menopause
- Hypothyroidism
- Male Hypogonadism
- Growth Hormone Deficiency
- Others
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- The U.K.
- Germany
- France
- Spain
- Italy
- Netherlands
- Sweden
- Switzerland
- Denmark
- Finland
- Russia
- Rest of Europe
- The Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Singapore
- Indonesia
- Taiwan
- Malaysia
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- The Middle East
- Africa